user

ENDRA Life Sciences and Rocky Vista University College of Osteopathic Medicine Partnering for Clinical Study of Thermo Acoustic Enhanced Ultrasound Device

ANN ARBOR, MI / ACCESSWIRE / July 1, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA), a developer of…

5 years ago

Do You Know Your Rights As A Blue Badge Holder?

There are plenty of rights and responsibilities to be aware of if you are a Blue Badge holder. Here, with…

5 years ago

Genmed identified in London Stock Exchange Group’s ‘1000 Companies to Inspire Britain’ 2019 report

June 28, 2019 – Genmed announces today that it has been identified as one of London Stock Exchange Group’s 1000…

5 years ago

Angle PLC Announces Holding(s) in Company

GUILDFORD, SURREY / ACCESSWIRE / June 28, 2019 / ANGLE plc (OTCQX: ANPCY) (AIM: AGL): TR-1: Standard form for notification…

5 years ago

ANGLE plc Announces Notice of Preliminary Results and Webcast

GUILDFORD, SURREY / ACCESSWIRE / June 28, 2019 / ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company,…

5 years ago

Jaguar Health Strengthens Company’s Balance Sheet by Reducing Approximately $10.5 Million of Debt Incurred to Effect 2017 Merger to Approximately $5.7 Million

Maturity Date of Remaining Merger-related Debt is December 31, 2020 SAN FRANCISCO, CA / ACCESSWIRE / June 28, 2019 /…

5 years ago

Elite Pharmaceuticals Announces Commercial Launch of Dantrolene Capsules with Marketing Partner Lannett Company

NORTHVALE, NJ / ACCESSWIRE / June 28, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB: ELTP) announced today…

5 years ago

Regulatory Updates from Health Canada and US FDA

TORONTO, ON / ACCESSWIRE / June 27, 2019 /Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV: TLT) (OTCQB: TLTFF), a clinical…

5 years ago

NeoGenomics Announces New $250 Million Credit Agreement

FORT MYERS, FL / ACCESSWIRE / June 27, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic…

5 years ago

EastWest Science USA Signs Mutual US Distribution Agreement with CBD Manufacturer GM Health Wholesale

VANCOUVER, BC / ACCESSWIRE / June 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that its…

5 years ago

Aquarius Surgical Technologies Closes First Tranche of Private Placement

TORONTO, ON / ACCESSWIRE / June 27, 2019 / Aquarius Surgical Technologies Inc. (CSE: ASTI) ("Aquarius" or "the Company") today…

5 years ago

Theralase Files Prospectus for Offering of Units

Not for Distribution to United States Newswire Services or for Dissemination in the United States TORONTO, ON / ACCESSWIRE /…

5 years ago

Nursing & Midwifery Council to use Rizikon Assurance from Crossword Cybersecurity PLC to Automate Supplier Onboarding and Improve Supplier Risk Management

27th June 2019 – London, UK – Crossword Cybersecurity plc (AIM: CCS) has today announced that the Nursing and Midwifery…

5 years ago

Eggplant and iMethods Expand Relationship

iMethods attains Eggplant Endorsed Service Provider statusBoulder, CO, June 26, 2019: Eggplant the intelligent test automation specialist, today announced iMethods,…

5 years ago

Jaguar Health Engages Integrium, LLC to Support Clinical Study Evaluating the Effect of Mytesi on the Microbiome

Study will Examine the Possible Benefits of Mytesi® on Gut Health, Including Bloating and Abdominal Discomfort, in People Living with…

5 years ago

StageZero Life Sciences Ltd Announces Initiation Of Trading Under The Stock Trading Symbol SZLS

TORONTO, ON / ACCESSWIRE / June 26, 2019 / StageZero Life Sciences Ltd (Formerly GeneNews or the "Company") (TSX: GEN)…

5 years ago

Health Canada Approves Amended Clinical Trial Application

TORONTO, ON / ACCESSWIRE / June 26, 2019 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV: TLT) (OTCQB: TLTFF), a…

5 years ago

EyeGate Announces First Patient Enrolled in PRK Pivotal Study

WALTHAM, MA / ACCESSWIRE / June 26, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today…

5 years ago

Evotec Se Places First Schuldschein (Promissory Note) Worth Eur 250 M

PROCEEDS TO BE USED FOR GENERAL CORPORATE FINANCING INCLUDING FINANCING OF JUST.BIO ACQUISITION, EXPANSION, AND REFINANCING STRONG PERFORMANCE AND OUTLOOK…

5 years ago

Pharnext Announces the Apppointment of Peter Collum as Chief Financial Officer and Chief Business Officer

PARIS, FRANCE / ACCESSWIRE / June 26, 2019 / Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new…

5 years ago